HEADER    HYDROLASE/HYDROLASE INHIBITOR           11-NOV-13   4NJV              
TITLE     CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1   
TITLE    2 PROTEASE IN COMPLEX WITH RITONAVIR                                   
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEASE;                                                  
COMPND   3 CHAIN: A, B, C, D;                                                   
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE   3 ORGANISM_TAXID: 11676;                                               
SOURCE   4 GENE: POL;                                                           
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, RITONAVIR, RIT, PROTEASE        
KEYWDS   2 INHIBITOR, KALETRA, HYDROLASE-HYDROLASE INHIBITOR COMPLEX            
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    R.S.YEDIDI,H.GARIMELLA,S.B.CHANG,J.D.KAUFMAN,D.DAS,P.T.WINGFIELD,     
AUTHOR   2 H.MITSUYA                                                            
REVDAT   4   28-FEB-24 4NJV    1       REMARK                                   
REVDAT   3   25-JUN-14 4NJV    1       JRNL                                     
REVDAT   2   21-MAY-14 4NJV    1       JRNL                                     
REVDAT   1   02-APR-14 4NJV    0                                                
JRNL        AUTH   R.S.YEDIDI,H.GARIMELLA,M.AOKI,H.AOKI-OGATA,D.V.DESAI,        
JRNL        AUTH 2 S.B.CHANG,D.A.DAVIS,W.S.FYVIE,J.D.KAUFMAN,D.W.SMITH,D.DAS,   
JRNL        AUTH 3 P.T.WINGFIELD,K.MAEDA,A.K.GHOSH,H.MITSUYA                    
JRNL        TITL   A CONSERVED HYDROGEN-BONDING NETWORK OF P2                   
JRNL        TITL 2 BIS-TETRAHYDROFURAN-CONTAINING HIV-1 PROTEASE INHIBITORS     
JRNL        TITL 3 (PIS) WITH A PROTEASE ACTIVE-SITE AMINO ACID BACKBONE AIDS   
JRNL        TITL 4 IN THEIR ACTIVITY AGAINST PI-RESISTANT HIV.                  
JRNL        REF    ANTIMICROB.AGENTS CHEMOTHER.  V.  58  3679 2014              
JRNL        REFN                   ISSN 0066-4804                               
JRNL        PMID   24752271                                                     
JRNL        DOI    10.1128/AAC.00107-14                                         
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.80 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : PHENIX (PHENIX.REFINE: 1.8.1_1168)                   
REMARK   3   AUTHORS     : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN            
REMARK   3               : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,           
REMARK   3               : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,            
REMARK   3               : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,              
REMARK   3               : REETAL PAI,RANDY READ,JANE RICHARDSON,               
REMARK   3               : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,           
REMARK   3               : NICHOLAS SAUTER,JACOB SMITH,LAURENT                  
REMARK   3               : STORONI,TOM TERWILLIGER,PETER ZWART                  
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : ML                                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 34.81                          
REMARK   3   MIN(FOBS/SIGMA_FOBS)              : 1.360                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 96.1                           
REMARK   3   NUMBER OF REFLECTIONS             : 40761                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.188                           
REMARK   3   R VALUE            (WORKING SET) : 0.187                           
REMARK   3   FREE R VALUE                     : 0.216                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.040                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 2054                            
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (IN BINS).                           
REMARK   3   BIN  RESOLUTION RANGE  COMPL.    NWORK NFREE   RWORK  RFREE        
REMARK   3     1 34.8191 -  4.4465    0.99     2769   144  0.1743 0.1987        
REMARK   3     2  4.4465 -  3.5304    1.00     2697   127  0.1464 0.1640        
REMARK   3     3  3.5304 -  3.0845    1.00     2675   142  0.1808 0.1836        
REMARK   3     4  3.0845 -  2.8026    1.00     2743   141  0.2022 0.2389        
REMARK   3     5  2.8026 -  2.6018    1.00     2671   142  0.2126 0.2456        
REMARK   3     6  2.6018 -  2.4484    1.00     2675   137  0.2125 0.2617        
REMARK   3     7  2.4484 -  2.3258    1.00     2656   140  0.2074 0.2346        
REMARK   3     8  2.3258 -  2.2246    1.00     2673   148  0.1931 0.2392        
REMARK   3     9  2.2246 -  2.1390    1.00     2665   133  0.1787 0.2082        
REMARK   3    10  2.1390 -  2.0652    1.00     2698   150  0.1805 0.2356        
REMARK   3    11  2.0652 -  2.0006    1.00     2628   137  0.1869 0.2030        
REMARK   3    12  2.0006 -  1.9434    0.99     2633   151  0.2045 0.2726        
REMARK   3    13  1.9434 -  1.8923    0.95     2528   139  0.2200 0.2494        
REMARK   3    14  1.8923 -  1.8461    0.85     2259   127  0.2289 0.2599        
REMARK   3    15  1.8461 -  1.8000    0.65     1737    96  0.2436 0.2608        
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED        : FLAT BULK SOLVENT MODEL                       
REMARK   3   SOLVENT RADIUS     : 1.11                                          
REMARK   3   SHRINKAGE RADIUS   : 0.90                                          
REMARK   3   K_SOL              : NULL                                          
REMARK   3   B_SOL              : NULL                                          
REMARK   3                                                                      
REMARK   3  ERROR ESTIMATES.                                                    
REMARK   3   COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED)     : 0.170            
REMARK   3   PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.620           
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : NULL                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  TWINNING INFORMATION.                                               
REMARK   3   FRACTION: NULL                                                     
REMARK   3   OPERATOR: NULL                                                     
REMARK   3                                                                      
REMARK   3  DEVIATIONS FROM IDEAL VALUES.                                       
REMARK   3                 RMSD          COUNT                                  
REMARK   3   BOND      :  0.009           3336                                  
REMARK   3   ANGLE     :  1.279           4524                                  
REMARK   3   CHIRALITY :  0.086            512                                  
REMARK   3   PLANARITY :  0.005            564                                  
REMARK   3   DIHEDRAL  : 16.538           1256                                  
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  NCS DETAILS                                                         
REMARK   3   NUMBER OF NCS GROUPS : NULL                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 4NJV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-DEC-13.                  
REMARK 100 THE DEPOSITION ID IS D_1000083294.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 13-MAR-13                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.0                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 22-ID                              
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.0                                
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : MARMOSAIC 300 MM CCD               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000                           
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 40844                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.800                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 34.813                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : NULL                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : 0.08900                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.85                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.40                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.08900                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 18.71                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: BALBES                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 53.81                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 3.0 M SODIUM CHLORIDE (PRECIPITANT),     
REMARK 280  0.1 M HEPES (BUFFER), PH 7.0, VAPOR DIFFUSION, HANGING DROP,        
REMARK 280  TEMPERATURE 298K                                                    
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       29.10950            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 5280 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 9410 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 5300 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 9380 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   O    HOH D   674     O    HOH D   695              1.85            
REMARK 500   O    HOH D   661     O    HOH D   706              1.89            
REMARK 500   O    HOH C   139     O    HOH C   171              1.96            
REMARK 500   O    HOH A   629     O    HOH A   648              1.99            
REMARK 500   O    HOH D   640     O    HOH D   699              2.00            
REMARK 500   O    ILE C    50     O    HOH C   124              2.00            
REMARK 500   O    HOH C   176     O    HOH C   182              2.05            
REMARK 500   O    HOH C   167     O    HOH C   181              2.05            
REMARK 500   O    HOH D   667     O    HOH D   693              2.06            
REMARK 500   O    HOH A   622     O    HOH A   663              2.06            
REMARK 500   O    HOH C   165     O    HOH C   180              2.06            
REMARK 500   OG1  THR C     4     O    HOH C   169              2.09            
REMARK 500   O    HOH D   684     O    HOH D   694              2.11            
REMARK 500   OD1  ASP B    30     O    HOH B   165              2.11            
REMARK 500   OD1  ASP B    35     NH2  ARG B    57              2.12            
REMARK 500   OD2  ASP A    30     O    HOH A   666              2.13            
REMARK 500   O    HOH C   174     O    HOH C   177              2.13            
REMARK 500   O    ILE A    50     O    HOH A   623              2.14            
REMARK 500   O    HOH B   161     O    HOH B   163              2.15            
REMARK 500   O    HOH C   160     O    HOH C   172              2.16            
REMARK 500   O    HOH C   111     O    HOH C   151              2.16            
REMARK 500   O    HOH B   176     O    HOH B   177              2.18            
REMARK 500   O    HOH D   627     O    HOH D   630              2.18            
REMARK 500   OE2  GLU C    37     O    HOH C   163              2.18            
REMARK 500   O    HOH A   619     O    HOH A   650              2.18            
REMARK 500   O    HOH A   622     O    HOH B   166              2.19            
REMARK 500   O    HOH D   601     O    HOH D   678              2.19            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS                                             
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC             
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT.  AN ATOM LOCATED WITHIN 0.15          
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A           
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375             
REMARK 500 INSTEAD OF REMARK 500.  ATOMS WITH NON-BLANK ALTERNATE               
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.            
REMARK 500                                                                      
REMARK 500 DISTANCE CUTOFF:                                                     
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS              
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS                  
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI  SSYMOP   DISTANCE          
REMARK 500   O    HOH A   654     O    HOH B   166     2655     2.08            
REMARK 500   O    HOH A   664     O    HOH B   189     2655     2.10            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 630                                                                      
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR                                
REMARK 630 MOLECULE NAME: RITONAVIR                                             
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 630  SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                           
REMARK 630                                                                      
REMARK 630   M RES C SSSEQI                                                     
REMARK 630     RIT A   500                                                      
REMARK 630     RIT D   500                                                      
REMARK 630 SOURCE: NULL                                                         
REMARK 630 TAXONOMY: NULL                                                       
REMARK 630 SUBCOMP:    013 015 VAL 019                                          
REMARK 630 DETAILS: NULL                                                        
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIT A 500                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RIT D 500                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 4NJS   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1  
REMARK 900 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL008              
REMARK 900 RELATED ID: 4NJT   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1  
REMARK 900 PROTEASE IN COMPLEX WITH DARUNAVIR                                   
REMARK 900 RELATED ID: 4NJU   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1  
REMARK 900 PROTEASE IN COMPLEX WITH TIPRANAVIR                                  
DBREF  4NJV A    1    99  UNP    Q9J006   Q9J006_9HIV1     1     99             
DBREF  4NJV B    1    99  UNP    Q9J006   Q9J006_9HIV1     1     99             
DBREF  4NJV C    1    99  UNP    Q9J006   Q9J006_9HIV1     1     99             
DBREF  4NJV D    1    99  UNP    Q9J006   Q9J006_9HIV1     1     99             
SEQRES   1 A   99  PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE          
SEQRES   2 A   99  LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 A   99  GLY ALA ASP ASP THR VAL LEU GLU ASP MET GLU LEU PRO          
SEQRES   4 A   99  GLY ARG TRP LYS PRO ARG MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 A   99  PHE VAL LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU          
SEQRES   6 A   99  ILE CYS GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 A   99  PRO THR PRO THR ASN ILE ILE GLY ARG ASN LEU MET THR          
SEQRES   8 A   99  GLN LEU GLY PHE THR LEU ASN PHE                              
SEQRES   1 B   99  PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE          
SEQRES   2 B   99  LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 B   99  GLY ALA ASP ASP THR VAL LEU GLU ASP MET GLU LEU PRO          
SEQRES   4 B   99  GLY ARG TRP LYS PRO ARG MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 B   99  PHE VAL LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU          
SEQRES   6 B   99  ILE CYS GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 B   99  PRO THR PRO THR ASN ILE ILE GLY ARG ASN LEU MET THR          
SEQRES   8 B   99  GLN LEU GLY PHE THR LEU ASN PHE                              
SEQRES   1 C   99  PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE          
SEQRES   2 C   99  LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 C   99  GLY ALA ASP ASP THR VAL LEU GLU ASP MET GLU LEU PRO          
SEQRES   4 C   99  GLY ARG TRP LYS PRO ARG MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 C   99  PHE VAL LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU          
SEQRES   6 C   99  ILE CYS GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 C   99  PRO THR PRO THR ASN ILE ILE GLY ARG ASN LEU MET THR          
SEQRES   8 C   99  GLN LEU GLY PHE THR LEU ASN PHE                              
SEQRES   1 D   99  PRO GLN ILE THR LEU TRP GLN ARG PRO ILE VAL THR ILE          
SEQRES   2 D   99  LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 D   99  GLY ALA ASP ASP THR VAL LEU GLU ASP MET GLU LEU PRO          
SEQRES   4 D   99  GLY ARG TRP LYS PRO ARG MET ILE GLY GLY ILE GLY GLY          
SEQRES   5 D   99  PHE VAL LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU          
SEQRES   6 D   99  ILE CYS GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 D   99  PRO THR PRO THR ASN ILE ILE GLY ARG ASN LEU MET THR          
SEQRES   8 D   99  GLN LEU GLY PHE THR LEU ASN PHE                              
HET    RIT  A 500     100                                                       
HET    RIT  D 500     100                                                       
HETNAM     RIT RITONAVIR                                                        
HETSYN     RIT A-84538                                                          
FORMUL   5  RIT    2(C37 H48 N6 O5 S2)                                          
FORMUL   7  HOH   *359(H2 O)                                                    
HELIX    1   1 GLY A   86  THR A   91  1                                   6    
HELIX    2   2 GLN A   92  GLY A   94  5                                   3    
HELIX    3   3 GLY B   86  GLY B   94  1                                   9    
HELIX    4   4 GLY C   86  THR C   91  1                                   6    
HELIX    5   5 GLN C   92  GLY C   94  5                                   3    
HELIX    6   6 GLY D   86  THR D   91  1                                   6    
HELIX    7   7 GLN D   92  GLY D   94  5                                   3    
SHEET    1   A 4 GLN A   2  ILE A   3  0                                        
SHEET    2   A 4 THR B  96  ASN B  98 -1  O  LEU B  97   N  ILE A   3           
SHEET    3   A 4 THR A  96  ASN A  98 -1  N  THR A  96   O  ASN B  98           
SHEET    4   A 4 GLN B   2  ILE B   3 -1  O  ILE B   3   N  LEU A  97           
SHEET    1   B 8 TRP A  42  GLY A  49  0                                        
SHEET    2   B 8 GLY A  52  ILE A  66 -1  O  GLN A  58   N  LYS A  43           
SHEET    3   B 8 HIS A  69  GLY A  78 -1  O  VAL A  71   N  ILE A  64           
SHEET    4   B 8 THR A  31  GLU A  34  1  N  LEU A  33   O  LEU A  76           
SHEET    5   B 8 ILE A  84  ILE A  85 -1  O  ILE A  84   N  VAL A  32           
SHEET    6   B 8 GLN A  18  LEU A  24  1  N  LEU A  23   O  ILE A  85           
SHEET    7   B 8 ILE A  10  VAL A  15 -1  N  VAL A  11   O  ALA A  22           
SHEET    8   B 8 GLY A  52  ILE A  66 -1  O  GLU A  65   N  LYS A  14           
SHEET    1   C 8 LYS B  43  GLY B  49  0                                        
SHEET    2   C 8 GLY B  52  ILE B  66 -1  O  GLN B  58   N  LYS B  43           
SHEET    3   C 8 HIS B  69  VAL B  77 -1  O  HIS B  69   N  ILE B  66           
SHEET    4   C 8 VAL B  32  LEU B  33  1  N  LEU B  33   O  LEU B  76           
SHEET    5   C 8 ILE B  84  ILE B  85 -1  O  ILE B  84   N  VAL B  32           
SHEET    6   C 8 GLN B  18  LEU B  24  1  N  LEU B  23   O  ILE B  85           
SHEET    7   C 8 ILE B  10  VAL B  15 -1  N  ILE B  13   O  LYS B  20           
SHEET    8   C 8 GLY B  52  ILE B  66 -1  O  GLU B  65   N  LYS B  14           
SHEET    1   D 4 GLN C   2  ILE C   3  0                                        
SHEET    2   D 4 THR D  96  ASN D  98 -1  O  LEU D  97   N  ILE C   3           
SHEET    3   D 4 THR C  96  ASN C  98 -1  N  ASN C  98   O  THR D  96           
SHEET    4   D 4 GLN D   2  ILE D   3 -1  O  ILE D   3   N  LEU C  97           
SHEET    1   E 8 TRP C  42  GLY C  49  0                                        
SHEET    2   E 8 GLY C  52  ILE C  66 -1  O  VAL C  56   N  ARG C  45           
SHEET    3   E 8 HIS C  69  GLY C  78 -1  O  HIS C  69   N  ILE C  66           
SHEET    4   E 8 THR C  31  GLU C  34  1  N  LEU C  33   O  LEU C  76           
SHEET    5   E 8 ILE C  84  ILE C  85 -1  O  ILE C  84   N  VAL C  32           
SHEET    6   E 8 GLN C  18  LEU C  24  1  N  LEU C  23   O  ILE C  85           
SHEET    7   E 8 ILE C  10  VAL C  15 -1  N  ILE C  13   O  LYS C  20           
SHEET    8   E 8 GLY C  52  ILE C  66 -1  O  GLU C  65   N  LYS C  14           
SHEET    1   F 8 LYS D  43  GLY D  49  0                                        
SHEET    2   F 8 GLY D  52  ILE D  66 -1  O  GLY D  52   N  GLY D  49           
SHEET    3   F 8 LYS D  70  VAL D  77 -1  O  VAL D  77   N  ARG D  57           
SHEET    4   F 8 VAL D  32  LEU D  33  1  N  LEU D  33   O  LEU D  76           
SHEET    5   F 8 ILE D  84  ILE D  85 -1  O  ILE D  84   N  VAL D  32           
SHEET    6   F 8 GLN D  18  LEU D  24  1  N  LEU D  23   O  ILE D  85           
SHEET    7   F 8 ILE D  10  VAL D  15 -1  N  ILE D  13   O  LYS D  20           
SHEET    8   F 8 GLY D  52  ILE D  66 -1  O  GLU D  65   N  LYS D  14           
SITE     1 AC1 31 ARG A   8  ASP A  25  GLY A  27  ALA A  28                    
SITE     2 AC1 31 ASP A  29  ASP A  30  VAL A  32  GLY A  48                    
SITE     3 AC1 31 GLY A  49  ILE A  50  PRO A  81  THR A  82                    
SITE     4 AC1 31 ILE A  84  HOH A 603  HOH A 628  HOH A 633                    
SITE     5 AC1 31 HOH A 666  ARG B   8  ASP B  25  GLY B  27                    
SITE     6 AC1 31 ALA B  28  ASP B  29  ASP B  30  GLY B  48                    
SITE     7 AC1 31 GLY B  49  ILE B  50  PRO B  81  THR B  82                    
SITE     8 AC1 31 ILE B  84  HOH B 107  HOH B 164                               
SITE     1 AC2 30 ARG C   8  ASP C  25  GLY C  27  ALA C  28                    
SITE     2 AC2 30 ASP C  29  VAL C  32  ILE C  47  GLY C  48                    
SITE     3 AC2 30 GLY C  49  ILE C  50  PRO C  81  THR C  82                    
SITE     4 AC2 30 ILE C  84  HOH C 159  ARG D   8  ASP D  25                    
SITE     5 AC2 30 GLY D  27  ALA D  28  ASP D  29  ASP D  30                    
SITE     6 AC2 30 GLY D  48  GLY D  49  ILE D  50  PRO D  81                    
SITE     7 AC2 30 THR D  82  ILE D  84  HOH D 602  HOH D 612                    
SITE     8 AC2 30 HOH D 654  HOH D 696                                          
CRYST1   45.952   58.219   86.866  90.00  90.02  90.00 P 1 21 1      8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.021762  0.000000  0.000007        0.00000                         
SCALE2      0.000000  0.017177  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.011512        0.00000